generic glp-1 drugs List of approved and pending medications Connecticut wants to lower rising
Description
Serious side effects are uncommon but can include pancreatitis or dehydration if dosing guidelines aren't followed
After some months of deliberation Knudsen decided the best way forward was to find something that could protect the GLP-1 molecule

Incretin therapies: highlighting common features and differences in the modes of action of glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors
:max_bytes(150000):strip_icc()/health-GettyImages-2025836701-ce3f5ccf0f98428e9d14abaeb07ba307.jpg)
doi: 10.1172/JCI104891 62 MalekASagerRZakherASchneiderH
